Paresh Dandona, MD
Enriched profileSUNY Distinguished Professor of Medicine; Chief, Division of Endocrinology, Diabetes and Metabolism · University at Buffalo
Paresh Dandona is SUNY Distinguished Professor of Medicine; Chief, Division of Endocrinology, Diabetes and Metabolism at University at Buffalo. OpenAlex indexes 777 publications with 34,652 citations (h-index 95); ClinicalTrials.gov lists 19 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Paresh Dandona, MD, is SUNY Distinguished Professor of Medicine at University at Buffalo, Jacobs School of Medicine and Biomedical Sciences (SUNY). The public record shows 777 publications with 34,652 citations (h-index 95), centered on Type 2 Diabetes, Type 1 Diabetes, Obesity. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 2 companies, 3 NIH-funded awards (2005–2016).
- Most recent indexed publication: 2021 · Diabetes care
- Top research focus: Type 2 Diabetes
- 19 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- Role of Transcranial Direct Current Stimulation in Appetite and Weight Control
Sponsor: University at Buffalo
- Pioglitazone and Insulin Resistance in ADT
Sponsor: State University of New York at Buffalo
- Anti-inflammatory Effects of Simvastatin
Sponsor: paresh Dandona
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- Marius Pharmaceuticals, LLCProgram year20231 payment
- Novo Nordisk IncProgram year20213 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
68.9%GLP-1 receptor agonist19.7%Ozempic63%Mounjaro24%Trulicity10%Rybelsus3%Part D<11 patientsThiazolidinedione15.9%Pioglitazone Hcl100%Part D≥221 patientsCardiovascular
14%Statin7.8%Rosuvastatin Calcium52%Atorvastatin Calcium41%Pravastatin Sodium7%Part D<11 patientsAldosterone antagonist (MRA)1.5%Spironolactone100%Part D≥23 patientsHormonal (systemic)
9.4%l-Thyroxine8.7%Levothyroxine Sodium92%Synthroid8%Part D≥112 patientsThyroid Hormone Synthesis Inhibitor0.4%Methimazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2005–2016 per NIH RePORTER. The latest:
- LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
State University of New York at Buffalo
FY2016$274,263R01DK092653 - LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
State University of New York at Buffalo
FY2015$273,754R01DK092653 - LIRAGLUTIDE AS ADDITIONAL TREATMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
State University of New York at Buffalo
FY2014$273,754R01DK092653
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Dapagliflozin reduces systolic blood pressure and modulates vasoactive factors.
Diabetes, obesity & metabolism
Clinical Trial2021 - Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review.
Diabetes, obesity & metabolism
Review2021 - Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss.
Diabetes, obesity & metabolism
Clinical Trial2020
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/paresh-dandona-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Paresh-Dandona-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/dandona-paresh-24b23748
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
en.wikipedia.org/wiki/Paresh_Dandona
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗ - Other
cardiometabolichealth.org/faculty/paresh-dandona
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ubmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ubmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ubmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ubmd.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗
Editorial & leadership roles
journal and society appointments- Editorial Board
Diabetes Care (American Diabetes Association journal)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗ - Founding Editor
Metabolic Syndrome and Related Disorders
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asndi.org ↗ - Editorial board member (past)
Journal of Clinical Endocrinology & Metabolism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asndi.org ↗
Awards & honors
honors on the public record- Lifetime Achievement Award
The Androgen Society (2023), for research on testosterone deficiency, insulin resistance, and Type 2 diabetes; presented at the Androgen Society annual meeting, Dallas, TX, March 2023 …
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buffalo.edu ↗ - Lifetime Contribution Award
Madras Diabetes Research Foundation (2020), presented in Chennai, India, July 2020; 8th physician-scientist to receive the award
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗ - Pharmacia-Pfizer/Endocrine Society Award (2002)
for discovery of the anti-inflammatory effect of insulin
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.buffalo.edu ↗
- Practicing physician
UBMD Internal Medicine (at Amherst)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ubmd.com ↗ - Former Director
Diabetes and Metabolism, Royal Free Hospital School of Medicine, University of London (14 years)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buffalo.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesincontrol.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buffalo.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Anne Curtis, MD
University at Buffalo
Gil Wolfe, MD
University at Buffalo
Uriel Halbreich, MD
University at Buffalo
Patricia Diaz, MD
University at Buffalo